about
Exercise after breast cancer treatment: current perspectivesPhysical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivorsTopical tacrolimus for the treatment of secondary lymphedema.Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivorsEffectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial.Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0T MRI to external measuresWeight lifting in patients with lower-extremity lymphedema secondary to cancer: a pilot and feasibility study.Lifestyle risk factors associated with arm swelling among women with breast cancer.A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues.Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life.Association between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema.A lymphedema self-management programme: report on 30 casesA hybrid effectiveness-implementation trial of an evidence-based exercise intervention for breast cancer survivors.Incidence and Severity of Lymphoedema following Limb Salvage of Extremity Soft Tissue Sarcoma.Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care.Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity.Validity of Quantitative Lymphoscintigraphy as a Lymphedema Assessment Tool for Patients With Breast Cancer.Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.Assessment of The Lymphatic System of the Genitalia Using Magnetic Resonance Lymphography Before and After Treatment of Male Genital Lymphedema.Race or Resource? BMI, Race, and Other Social Factors as Risk Factors for Interlimb Differences among Overweight Breast Cancer Survivors with Lymphedema.A randomized cross-over trial to detect differences in arm volume after low- and heavy-load resistance exercise among patients receiving adjuvant chemotherapy for breast cancer at risk for arm lymphedema: study protocolLymphedema following treatment for breast cancer: a new approach to an old problem.Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.Resistance exercise and secondary lymphedema in breast cancer survivors-a systematic review.Update on Post-mastectomy Lymphedema Management.Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema.Differences of symptoms in head and neck cancer patients with and without lymphedema.Robotic infrarenal paraaortic and pelvic nodal staging for endometrial cancer: feasibility and lymphatic complications.Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: a randomised controlled trial.Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges.Neither heavy nor light load resistance exercise acutely exacerbates lymphedema in breast cancer survivor.Incidence of lower limb lymphedema after vulvar cancer: A systematic review and meta-analysis.Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial.Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.Heavy-Load Lifting: Acute Response in Breast Cancer Survivors at Risk for Lymphedema.
P2860
Q26778893-736024E0-3F04-4600-98E1-4D45BCA8BAB8Q30489696-9F1AFF13-291A-4D56-86E5-DCFF1C54296AQ30838687-A56B3EAB-0DEC-4789-A524-DC210383E398Q33568391-4885B388-B528-4018-8215-DD87BE48ABCFQ33591122-0A58AE14-8467-42A0-B80B-8CDC9AD1B917Q33772743-7222382F-51B0-43BD-8B7F-88F2E81AC9D4Q33964824-306EAA6B-35FB-43E3-B182-A1E610EA75A5Q34004915-120FCE35-DF17-47BC-A6B1-4007602FFE00Q34266953-B64ABC28-EF49-4FF2-B501-13D4FCC14BFCQ34383994-5A03C5B7-C83B-4221-A61D-EFCC818D279FQ34724809-8B70F7C4-AEF1-40AE-A53B-5F308282EE96Q35132569-A5088A42-03FD-43F8-AEF8-7ADED6BB5190Q35487335-B8BDD08C-93EC-4A7B-9F69-6CFB734310B8Q35543995-1D2E441D-17A2-46A3-848B-C655F97E5B87Q35608739-079EE30B-39DA-4874-B00F-B832155DD81FQ35673034-69AF19B4-993E-4649-BDF4-292263427BB3Q35940177-DEFDDF7F-4B56-46E8-BBFA-064769364ECCQ36484754-B87F2199-3833-4598-8DE8-D993B68E7FF6Q36587170-8FCF64AA-5551-426D-A0B8-488E44E49009Q36992946-DB771CB6-8E4D-48E7-AF74-999857CAD9D6Q37084325-EA47C439-1D89-4F43-8DE8-017FBA0EE36CQ37119461-B1708884-27EC-4EFD-90FB-8A5139FF0D5CQ37200954-99DEE693-4ED7-4FFF-8547-AE159656BC45Q37210955-78FA6379-9327-473E-9C5B-4F192B660DF9Q37341815-BB903872-1284-4FF5-9F94-C5CF60434511Q38001373-C2B927B7-44A3-4645-9B1B-3319133D323DQ38682543-BF89151D-DA63-4060-8BF4-5A3CD78F02A9Q38885195-836244FF-1493-46E9-9A1D-ABF7876C3BE0Q40053399-5BC8D32B-6E2E-4DEC-8366-464092789940Q40599510-CE920A02-969B-4633-944A-12C8D89936F1Q40686187-4816437F-2E03-4624-AD02-9F4F6CF1558DQ40872781-2172C06C-573D-442C-A3C9-21BB5D4898C1Q44073955-93709057-F46F-4DBF-B5F5-ACDEDBD99F13Q44078724-FFAC0025-C219-45DD-94AE-ADF2F9E73F8BQ44717878-EAC09A0B-8627-4698-9FF1-1F42F7D2B0B1Q47137384-07E5EB2D-408C-4CE9-B8E5-922EA11F383BQ47376980-40E77C3E-41D0-42F0-850E-8EF0F507A14AQ47569260-6311BF49-2800-4CF4-879F-51BA737024E1Q47600192-FC636AAA-5294-4184-AB72-6DD8882E8594Q47657114-E05CE75A-3214-4ACD-A22B-2AD39A14D11B
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The grading of lymphedema in oncology clinical trials.
@ast
The grading of lymphedema in oncology clinical trials.
@en
type
label
The grading of lymphedema in oncology clinical trials.
@ast
The grading of lymphedema in oncology clinical trials.
@en
prefLabel
The grading of lymphedema in oncology clinical trials.
@ast
The grading of lymphedema in oncology clinical trials.
@en
P2093
P1476
The grading of lymphedema in oncology clinical trials.
@en
P2093
Andrea L Cheville
Charles L McGarvey
Jeanne A Petrek
Marie E Taylor
Sandra A Russo
Saskia R J Thiadens
P304
P356
10.1016/S1053-4296(03)00038-9
P577
2003-07-01T00:00:00Z